Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Stock Information for Lucid Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lucid Diagnostics Inc.

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.